TREATMENT OF HER2-POSITIVE CANCER WITH PACLITAXEL AND TRASTUZUMAB-MCC-DM1,申请号WO2011US63764-传众专利搜索

发明名称	TREATMENT OF HER2-POSITIVE CANCER WITH PACLITAXEL AND TRASTUZUMAB-MCC-DM1
摘要	The present invention relates to combination therapy with paclitaxel, trastuzumab-MCC-DM1 and optionally, pertuzumab.
申请公布号	WO2012078771(A1)	申请公布日期	2012.06.14
申请号	WO2011US63764	申请日期	2011.12.07
申请人	GENENTECH, INC.;F. HOFFMANN-LA ROCHE AG;KLENCKE, BARBARA;HOLDEN, SCOTT;GUARDINO, ALICE;ALTHAUS, BETSY	发明人	KLENCKE, BARBARA;HOLDEN, SCOTT;GUARDINO, ALICE;ALTHAUS, BETSY
分类号	A61K31/337;A61K39/395;A61P35/00	主分类号	A61K31/337
代理机构		代理人
主权项
地址